Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerGuidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer CellsαV integrins in angiogenesis and cancerCombination of RGD compound and low-dose paclitaxel induces apoptosis in human glioblastoma cellsIntegrins in cancer: biological implications and therapeutic opportunitiesNeoplasia: the second decade.Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner.Hypoxia, inflammation, and the tumor microenvironment in metastatic diseaseCrosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cellsN-myc downstream-regulated gene 1 inhibits the proliferation and invasion of hepatocellular carcinoma cells via the regulation of integrin β3Targeted gene silencing using RGD-labeled chitosan nanoparticles.Stem cell pathways contribute to clinical chemoresistance in ovarian cancerThe potential of nanomedicine therapies to treat neovascular disease in the retina.Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation.Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review)In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancerProduction and characterization of a humanized single-chain antibody against human integrin alphav beta3 proteinTargeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.Selective Tumor Targeting of Desacetyl Vinblastine Hydrazide and Tubulysin B via Conjugation to a Cholecystokinin 2 Receptor (CCK2R) LigandIntegrin inhibitors as a therapeutic agent for ovarian cancerHuman beta-galactoside alpha-2,3-sialyltransferase (ST3Gal III) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity.Smoothened antagonists reverse taxane resistance in ovarian cancer.Combined in vivo molecular and anatomic imaging for detection of ovarian carcinoma-associated protease activity and integrin expression in mice.Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancerActivin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signalingSynstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis.The War on Cancer rages on.Outside-in integrin signalling regulates haematopoietic stem cell function via Periostin-Itgav axis.Novel approach for the detection of intraperitoneal micrometastasis using an ovarian cancer mouse model.Metronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancer.Liposomes targeting tumour stromal cells.Targeting integrins in hepatocellular carcinoma.Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer?Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors.Integrin-mediated cell-matrix interaction in physiological and pathological blood vessel formation.RGD-mediated delivery of small-molecule drugs.The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation.Radiolabeled RGD tracer kinetics annotates differential αvβ 3 integrin expression linked to cell intrinsic and vessel expression.Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review.Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin.
P2860
Q24628746-3B028413-0712-4618-8312-48D7619E0AE3Q26738643-84FB0CB2-D571-4F24-B4CF-B3D76CDAA1E8Q26851768-A3E84395-2136-4335-BE8D-D8371DBFBC7CQ28483911-F438F18C-BA4C-4DAA-803C-D08EDFADE6CAQ29614536-2760A220-AF08-4F16-AF73-5E186E85990DQ30484000-5E140730-15C7-475D-8BB2-BF66CCCE8978Q30640795-EC7B4E07-DFB0-4198-A7D9-7A6A7CFFCDF6Q33576030-2B8C8D58-67F8-4031-8E88-4D0E66194C74Q33648443-E4489043-9B24-44D5-9499-A0B0594129B8Q33685302-10230668-1094-44CD-A702-1FACF451B521Q34031859-78D18491-DB78-4E7D-AF64-0F4417F88E44Q34092005-6AC699AB-D824-4541-85BA-BFC89A360320Q34220590-FC120570-7035-42F1-906D-E05DFE9F7E80Q34355442-DC2EC429-C7CE-40B7-9A06-04319D27CBA4Q34433546-3B857AB8-A39B-4206-987A-AF1EEF0C6659Q34674722-DAC9D033-0D4F-49A7-A8A2-7220EDC87615Q35085202-504B0F6B-B3B9-4A55-95AB-1E4E95FC6254Q35374753-86EFE8EE-5FF6-4017-AEE9-F4C4D689ABADQ35652998-1149DEE3-A73C-45F4-AC02-6E2AB20A9855Q35660004-D82A98AF-0472-4A43-810D-F496C95D6AFCQ35668911-235D15CC-3796-4443-A400-BC814D1B3F95Q36084215-46958A72-003C-42C0-B2D4-9C6D94CB6EDAQ36088158-22705364-ABCF-41D0-A7A6-37A0774D17DAQ36104744-ACE2D7BE-DFE6-4A13-BA40-9FF494A2B427Q36544657-35295F8A-8279-470F-AB6E-BC10ABEE3505Q36836804-0B84A127-7C99-485F-8B4D-83E84F6C6E39Q37478602-808FD790-3AC7-4D7C-930B-0F5F6D2C40CEQ37486934-DF77559A-D00B-4694-81F5-3B57CDD4E33EQ37604850-63ADB22B-B323-4EDC-B7D6-053EE7762CC3Q37717741-9DD4A668-60D0-404A-BBEA-406A6A939ADBQ37799613-E642925B-F5F9-432C-979B-3265949F57DDQ37844564-118E2445-2CA8-4D2F-ABCE-CE0B92690288Q38209789-5A911F2E-7618-460D-BAF0-DEED08EAAA1FQ38399145-DC8A62A4-85CE-4D32-AAE1-CFD6C49B1690Q38501776-6718416E-1FE5-4565-8B46-939A03FF19A4Q38732486-174FAD21-860F-437E-A941-74D7E99C90FCQ38854040-785EB25D-686B-492A-964C-B328C9950C3DQ39047828-93229C2D-FCAB-4441-8CED-261BAB41F72AQ39429469-1B808859-94CA-46FA-9BB3-C39CDC45456AQ39720176-3498E545-00A1-4961-91C7-CF7908877C1B
P2860
Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Tumor-selective response to an ...... ta3 integrin in ovarian cancer
@ast
Tumor-selective response to an ...... ta3 integrin in ovarian cancer
@en
Tumor-selective response to an ...... ta3 integrin in ovarian cancer
@nl
type
label
Tumor-selective response to an ...... ta3 integrin in ovarian cancer
@ast
Tumor-selective response to an ...... ta3 integrin in ovarian cancer
@en
Tumor-selective response to an ...... ta3 integrin in ovarian cancer
@nl
prefLabel
Tumor-selective response to an ...... ta3 integrin in ovarian cancer
@ast
Tumor-selective response to an ...... ta3 integrin in ovarian cancer
@en
Tumor-selective response to an ...... ta3 integrin in ovarian cancer
@nl
P2093
P2860
P3181
P356
P1433
P1476
Tumor-selective response to an ...... ta3 integrin in ovarian cancer
@en
P2093
Alpa M Nick
Anil K Sood
Aparna A Kamat
Charles N Landen
David Tice
Nicholas B Jennnings
Tae-Jin Kim
Whitney A Spannuth
William M Merritt
P2860
P304
P3181
P356
10.1593/NEO.08740
P407
P577
2008-11-01T00:00:00Z